News Conference News TCT 2016 COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events Michael O'Riordan November 01, 2016
News Industry News Sudy Indicates PCI Of NIRS-Defined Lipid-Rich Plaque Is Safe And Not Associated With A Greater Incidence Of Adverse Outcomes Compared To PCI of Non Lipid-Rich Plaque November 01, 2016
News Daily News More Bang, Less Buck: Cost-Effectiveness Analysis Says Price of PCSK9 Inhibitors Needs to Drop by Two-Thirds Yael L. Maxwell August 29, 2016
News Daily News Más con Menos: Un Análisis de Rentabilidad Dice que Hay que Reducir en Dos Tercios el Precio de PCSK9 Yael L. Maxwell August 29, 2016
News Conference News ESC 2016 Platelet Function Testing to Guide Treatment Does Not Benefit Elderly ACS Patients: ANTARCTIC Todd Neale August 28, 2016
News Daily News Thin-Cap Fibroatheromas May Help Explain Poor PCI Outcomes in Diabetic Patients Todd Neale July 06, 2016
News Daily News Los Fibroateromas de Casquete Fino Podrían Explicar los Malos Resultados PCI de los Pacientes Diabéticos Todd Neale July 06, 2016
News Daily News Protein-Based Risk Score Shows Potential for Tailored Medicine in Cardiology Yael L. Maxwell June 24, 2016
News Daily News Un Nuevo Análisis Cuestiona el Mantra ‘Mejor Menos’, aunque los Expertos Piden Cautela Todd Neale June 22, 2016
News Daily News ‘Lower Is Better’ Mantra for LDL Cholesterol Questioned by New Analysis, but Experts Urge Caution Todd Neale June 22, 2016
News Conference News EAS 2016 Non-HDL Cholesterol, Inflammation Appear to Be Linked in Patients Undergoing Elective PCI Yael L. Maxwell June 08, 2016
News Daily News Anti-Inflammatory Drug Does Not Halt Plaque Progression in Overweight Patients With CAD Todd Neale May 27, 2016
News Daily News Dietary Habits May Aid Secondary Prevention in Patients With Stable CHD Caitlin E. Cox April 25, 2016
News Daily News El Controvertido Ensayo LIGHT Ahora Publicado No Arroja Luz sobre los Riesgos CV de Contrave Michael O'Riordan March 08, 2016
News Daily News Controversial LIGHT Trial Now Published but Fails to Illuminate CV Risks of Contrave Michael O'Riordan March 08, 2016